Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$18.5M
Filings
113
Firms Hired
3
Active Period
2001–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Mainstreaming Addiction Treatment Act of 2021
2021 · fourth_quarter · Firm: PURDUE PHARMA, LP
Monitored activity on bills that seek to improve access to substance use disorder treatment by removing certain barriers to care.: H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021, H.R. 4203 IMPROVE Addiction Care Act, and H.R. 955 / S. 285 Medicaid Reentry Act of 2021.
Client expense: $118,375 · Firm income: —
Matched citations: H.R. 1384
Lower Costs, More Cures Act of 2021
2021 · fourth_quarter · Firm: PURDUE PHARMA, LP
Monitored congressional activity on legislation to address prescription drug prices in the Medicare and Medicaid programs (H.R. 19 - Lower Costs, More Cures Act of 2021, and H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act).
Client expense: $118,375 · Firm income: —
Matched citations: H.R. 19
Monitored ongoing congressional activity pertaining to bankruptcy reforms and use of non-debtor releases in bankruptcy (H.R. 2096 / S. 2472 and H.R. 4777 / 2497), including outreach regarding committee hearings held on these issues and potential future hearings and activity on the legislation.
Client expense: $118,375 · Firm income: —
Matched citations: H.R. 2096
Elijah E. Cummings Lower Drug Costs Now Act
2021 · fourth_quarter · Firm: PURDUE PHARMA, LP
Monitored congressional activity on legislation to address prescription drug prices in the Medicare and Medicaid programs (H.R. 19 - Lower Costs, More Cures Act of 2021, and H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act).
Client expense: $118,375 · Firm income: —
Matched citations: H.R. 3
Monitored activity on bills that seek to improve access to substance use disorder treatment by removing certain barriers to care.: H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021, H.R. 4203 IMPROVE Addiction Care Act, and H.R. 955 / S. 285 Medicaid Reentry Act of 2021.
Client expense: $118,375 · Firm income: —
Matched citations: H.R. 4203
Nondebtor Release Prohibition Act of 2021
2021 · fourth_quarter · Firm: PURDUE PHARMA, LP
Monitored ongoing congressional activity pertaining to bankruptcy reforms and use of non-debtor releases in bankruptcy (H.R. 2096 / S. 2472 and H.R. 4777 / 2497), including outreach regarding committee hearings held on these issues and potential future hearings and activity on the legislation.
Client expense: $118,375 · Firm income: —
Matched citations: H.R. 4777
Monitored activity on bills that seek to improve access to substance use disorder treatment by removing certain barriers to care.: H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021, H.R. 4203 IMPROVE Addiction Care Act, and H.R. 955 / S. 285 Medicaid Reentry Act of 2021.
Client expense: $118,375 · Firm income: —
Matched citations: H.R. 955
Monitored ongoing congressional activity pertaining to bankruptcy reforms and use of non-debtor releases in bankruptcy (H.R. 2096 / S. 2472 and H.R. 4777 / 2497), including outreach regarding committee hearings held on these issues and potential future hearings and activity on the legislation.
Client expense: $118,375 · Firm income: —
Matched citations: S. 2472
Monitored activity on bills that seek to improve access to substance use disorder treatment by removing certain barriers to care.: H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021, H.R. 4203 IMPROVE Addiction Care Act, and H.R. 955 / S. 285 Medicaid Reentry Act of 2021.
Client expense: $118,375 · Firm income: —
Matched citations: S. 285
Mainstreaming Addiction Treatment Act of 2021
2021 · third_quarter · Firm: PURDUE PHARMA, LP
Monitored activity on bills that seek to improve access to substance use disorder treatment by removing certain barriers to care.: H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021, H.R. 4203 IMPROVE Addiction Care Act, and H.R. 955 / S. 285 Medicaid Reentry Act of 2021.
Client expense: $118,375 · Firm income: —
Matched citations: H.R. 1384
Lower Costs, More Cures Act of 2021
2021 · third_quarter · Firm: PURDUE PHARMA, LP
Monitored congressional activity on legislation to address prescription drug prices in the Medicare and Medicaid programs (H.R. 19 - Lower Costs, More Cures Act of 2021, and H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act).
Client expense: $118,375 · Firm income: —
Matched citations: H.R. 19
Monitored ongoing congressional activity pertaining to bankruptcy reforms and use of non-debtor releases in bankruptcy (H.R. 2096 / S. 2472 and H.R. 4777 / 2497), including outreach regarding committee hearings held on these issues and potential future hearings and activity on the legislation.
Client expense: $118,375 · Firm income: —
Matched citations: H.R. 2096
Elijah E. Cummings Lower Drug Costs Now Act
2021 · third_quarter · Firm: PURDUE PHARMA, LP
Monitored congressional activity on legislation to address prescription drug prices in the Medicare and Medicaid programs (H.R. 19 - Lower Costs, More Cures Act of 2021, and H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act).
Client expense: $118,375 · Firm income: —
Matched citations: H.R. 3
Monitored activity on bills that seek to improve access to substance use disorder treatment by removing certain barriers to care.: H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021, H.R. 4203 IMPROVE Addiction Care Act, and H.R. 955 / S. 285 Medicaid Reentry Act of 2021.
Client expense: $118,375 · Firm income: —
Matched citations: H.R. 4203
Nondebtor Release Prohibition Act of 2021
2021 · third_quarter · Firm: PURDUE PHARMA, LP
Monitored ongoing congressional activity pertaining to bankruptcy reforms and use of non-debtor releases in bankruptcy (H.R. 2096 / S. 2472 and H.R. 4777 / 2497), including outreach regarding committee hearings held on these issues and potential future hearings and activity on the legislation.
Client expense: $118,375 · Firm income: —
Matched citations: H.R. 4777
Monitored activity on bills that seek to improve access to substance use disorder treatment by removing certain barriers to care.: H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021, H.R. 4203 IMPROVE Addiction Care Act, and H.R. 955 / S. 285 Medicaid Reentry Act of 2021.
Client expense: $118,375 · Firm income: —
Matched citations: H.R. 955
Monitored ongoing congressional activity pertaining to bankruptcy reforms and use of non-debtor releases in bankruptcy (H.R. 2096 / S. 2472 and H.R. 4777 / 2497), including outreach regarding committee hearings held on these issues and potential future hearings and activity on the legislation.
Client expense: $118,375 · Firm income: —
Matched citations: S. 2472
Monitored activity on bills that seek to improve access to substance use disorder treatment by removing certain barriers to care.: H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021, H.R. 4203 IMPROVE Addiction Care Act, and H.R. 955 / S. 285 Medicaid Reentry Act of 2021.
Client expense: $118,375 · Firm income: —
Matched citations: S. 285
American Rescue Plan Act of 2021
2021 · second_quarter · Firm: PURDUE PHARMA, LP
H.R. 1319 - American Rescue Plan Act - monitored process for impacts to pharmaceutical industry supply chain and state aide contained in the latest COVID-19 relief bill. Monitored the confirmation hearings for nominated officials from the Department of Health and Human Services and Department of Justice H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021: Monitoring legislation that would expand access to substance use disorder treatment by removing certain barriers to care. H.R. 2096 - Stop Shielding Assets from Corporate Known Liability by Eliminating Non-Debtor Releases Act: monitoring bill that would amend bankruptcy law to prohibit federal bankruptcy courts from granting releases to non-debtor third parties against claims brought by governmental entities.
Client expense: $198,400 · Firm income: —
Matched citations: H.R. 1319
Mainstreaming Addiction Treatment Act of 2021
2021 · second_quarter · Firm: PURDUE PHARMA, LP
H.R. 1319 - American Rescue Plan Act - monitored process for impacts to pharmaceutical industry supply chain and state aide contained in the latest COVID-19 relief bill. Monitored the confirmation hearings for nominated officials from the Department of Health and Human Services and Department of Justice H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021: Monitoring legislation that would expand access to substance use disorder treatment by removing certain barriers to care. H.R. 2096 - Stop Shielding Assets from Corporate Known Liability by Eliminating Non-Debtor Releases Act: monitoring bill that would amend bankruptcy law to prohibit federal bankruptcy courts from granting releases to non-debtor third parties against claims brought by governmental entities.
Client expense: $198,400 · Firm income: —
Matched citations: H.R. 1384
H.R. 1319 - American Rescue Plan Act - monitored process for impacts to pharmaceutical industry supply chain and state aide contained in the latest COVID-19 relief bill. Monitored the confirmation hearings for nominated officials from the Department of Health and Human Services and Department of Justice H.R. 1384 - Mainstreaming Addiction Treatment Act of 2021: Monitoring legislation that would expand access to substance use disorder treatment by removing certain barriers to care. H.R. 2096 - Stop Shielding Assets from Corporate Known Liability by Eliminating Non-Debtor Releases Act: monitoring bill that would amend bankruptcy law to prohibit federal bankruptcy courts from granting releases to non-debtor third parties against claims brought by governmental entities.
Client expense: $198,400 · Firm income: —
Matched citations: H.R. 2096
American Rescue Plan Act of 2021
2021 · first_quarter · Firm: PURDUE PHARMA, LP
H.R. 1319 - American Rescue Plan Act - monitored process for impacts to pharmaceutical industry supply chain and state aide contained in the latest COVID-19 relief bill. Monitored the confirmation hearings for nominated officials from the Department of Health and Human Services and Department of Justice H.R. 1384 -- Mainstreaming Addiction Treatment Act of 2021 - monitoring introduction of bill designed to ease restrictions on prescribing medications for the treatment of substance use disorder.
Client expense: $211,881 · Firm income: —
Matched citations: H.R. 1319
Mainstreaming Addiction Treatment Act of 2021
2021 · first_quarter · Firm: PURDUE PHARMA, LP
H.R. 1319 - American Rescue Plan Act - monitored process for impacts to pharmaceutical industry supply chain and state aide contained in the latest COVID-19 relief bill. Monitored the confirmation hearings for nominated officials from the Department of Health and Human Services and Department of Justice H.R. 1384 -- Mainstreaming Addiction Treatment Act of 2021 - monitoring introduction of bill designed to ease restrictions on prescribing medications for the treatment of substance use disorder.
Client expense: $211,881 · Firm income: —
Matched citations: H.R. 1384
Elijah E. Cummings Lower Drug Costs Now Act
2020 · fourth_quarter · Firm: PURDUE PHARMA, LP
S.2543-Prescription Drug Pricing Reduction Act of 2019 and H.R.3 - Lower Drug Costs Now Act of 2019. Monitored activity impacting the pricing of prescription medicines. S.1662 & HR 3105 - Opioid Treatment Surge Act. Monitored activity that would have created new fees on opioid manufacturers. HR 8732 - Preventing Pill Mills Through Data Sharing Act. Monitored activity relating to reporting on the sale and distribution of controlled substsances.
Client expense: $209,625 · Firm income: —
Matched citations: H.R.3
S.2543-Prescription Drug Pricing Reduction Act of 2019 and H.R.3 - Lower Drug Costs Now Act of 2019. Monitored activity impacting the pricing of prescription medicines. S.1662 & HR 3105 - Opioid Treatment Surge Act. Monitored activity that would have created new fees on opioid manufacturers. HR 8732 - Preventing Pill Mills Through Data Sharing Act. Monitored activity relating to reporting on the sale and distribution of controlled substsances.
Client expense: $209,625 · Firm income: —
Matched citations: HR 3105
Source: Senate LDA